Interestingly, 29 of the 32 Cdc42 effectors have endometrial carcinoma in the top five cancer types where they are found altered, suggesting understanding and potentially targeting Cdc42 signalling in this cancer could have therapeutic benefit. The gene discussed is CDC42; the disease is endometrial carcinoma.